logo

For the Inventor, By the Inventor

Riverdale, NY, United States of America

John Roboz

This inventor holds 2 USPTO granted patents. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Roboz. Retrieved from https://idiyas.com/inventor/john-roboz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:

goldMedal2 out of 538 
 
Icahn School of Medicine at Mount Sinai
 patents

Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6590123 - Aminobenzoic acid derivatives having anti-tumorigenic activity, methods of making and using the same (2003-07-08),
2. 6294695 - Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same (2001-09-25),

Title: Innovations by John Roboz

Introduction

John Roboz is a notable inventor based in Riverdale, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-tumorigenic activity. With a total of 2 patents, his work has the potential to impact cancer treatment and research.

Latest Patents

Roboz's latest patents focus on aminobenzoic acid derivatives that exhibit anti-tumorigenic properties. One of his inventions provides for haloacetoamido, benzoic acid derivatives that have demonstrated effectiveness in this area. The examples of these derivatives include 3-chloroacetoamido, benzoylurea, 3-bromoacetoamido, benzoylurea, and 3-iodoacetoamido, benzoylurea, among others. Additionally, he has developed methods for synthesizing these derivatives, along with their applications in medical treatments.

Career Highlights

John Roboz is affiliated with the Mount Sinai School of Medicine, where he continues to advance his research and innovations. His work is characterized by a commitment to developing new therapeutic agents that can aid in the fight against cancer.

Collaborations

Roboz has collaborated with esteemed colleagues such as George J Bekesi and Jian-Dong Jiang. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the medical field.

Conclusion

John Roboz's contributions to medicinal chemistry and his innovative patents highlight his dedication to improving cancer treatment options. His work continues to inspire advancements in the field and offers hope for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…